Lifecycle of Plasmodium Vivax

The lifecycle of Plasmodium vivax is complex and involves two hosts: humans and female Anopheles mosquitoes. In humans, the parasite undergoes asexual reproduction through a process called schizogony, while in mosquitoes, it undergoes sexual reproduction through sporogony. 

Plasmodium vivax is a species of parasitic protozoa that causes malaria in humans. It is one of the most widespread malaria causes, with millions of cases reported annually.

Charles Louis Alphonse Laveran, a French army surgeon in Algeria, discovered Plasmodium vivax. In 1880, while examining the blood of a patient having malaria, Laveran observed a parasite inside the red blood cells. He later identified this parasite as a new species and named it Oscillaria malariae, later named Plasmodium vivax. Laveran was awarded the Nobel Prize in Physiology or Medicine in 1907 for discovering the malaria parasite.

Related: How to report Malaria Microscopy results

Understanding the lifecycle of this parasite is crucial for developing effective strategies to control and prevent the spread of malaria. This article will explore the different stages of the Plasmodium vivax lifecycle, from initial infection in humans to mosquito transmission and the potential for relapse.

1. 

Asexual or schizogony lifecycle of Plasmodium vivax in man

Asexual reproduction of the Plasmodium vivax parasite refers to the process by which the parasite multiplies within the human host without the fusion of gametes or the exchange of genetic material. This process is known as schizogony and takes place in two stages: liver schizogony and erythrocytic schizogony.

Asexual reproduction is crucial for the survival and spread of the malaria parasite within the human host. It is responsible for the symptoms of malaria and allows the parasite to multiply rapidly and evade the host’s immune system.

The asexual life cycle or schizogony in humans can be divided into four steps:

Infection

The infection stage is the first step in the asexual life cycle of the malaria parasite in the human host. This stage begins when an infected female Anopheles mosquito bites a person. During the blood meal, the mosquito injects anticoagulant saliva into the person’s skin to prevent blood clotting. Along with the saliva, the mosquito also injects sporozoites, the infective stage of the malaria parasite.

Once inside the human host, the sporozoites travel through the bloodstream to the liver. The sporozoites can evade the host’s immune system by rapidly changing their surface proteins and using specific receptors to bind to and invade liver cells.

Liver schizogony

Liver schizogony is the second stage in the asexual life cycle of the malaria parasite in the human host. This stage occurs within the liver cells and begins when sporozoites, injected into the human host by an infected mosquito, invade liver cells.

Once inside the liver cells, the sporozoites begin to multiply through a process called liver schizogony. The sporozoites undergo multiple division rounds during this stage, producing thousands of merozoites. These merozoites then move into the bloodstream, where they can invade red blood cells and begin the next stage of the asexual life cycle.

Liver schizogony is a crucial stage in the lifecycle of the malaria parasite. It allows the parasite to multiply rapidly within the liver and produce large numbers of merozoites, which can then spread throughout the body and cause disease. This stage is also essential for evading the host’s immune system, as the liver cells provide a protective environment in which the parasite can multiply undetected.

After liver schizogony is complete, the merozoites are released into the bloodstream. They can invade red blood cells, marking the beginning of the next stage in the asexual life cycle: erythrocytic schizogony.

Erythrocytic schizogony

Erythrocytic schizogony is the third stage in the asexual life cycle of the malaria parasite in the human host. This stage occurs within the red blood cells and begins when merozoites, released into the bloodstream from the liver, invade red blood cells.

Once inside the red blood cells, the merozoites begin to multiply through a process called erythrocytic schizogony. The merozoites undergo multiple division rounds during this stage, producing more merozoites. This results in the destruction of the red blood cells and the release of more merozoites into the bloodstream, which can invade other red blood cells and continue the cycle.

Erythrocytic schizogony is responsible for the symptoms of malaria, including fever, chills, and anemia. As the process destroys red blood cells, hemoglobin levels decrease, leading to anemia. The release of merozoites and other substances from the ruptured red blood cells also triggers an immune response, leading to fever and chills.

As this cycle continues, some merozoites develop into male and female gametocytes.

Erythrocytic schizogony is a crucial stage in the lifecycle of the malaria parasite. It allows the parasite to multiply rapidly within the red blood cells and cause disease. Understanding this stage is vital for developing effective treatments and prevention strategies.

Formation of gametocytes

Gametocytes are the sexual forms of the Plasmodium vivax parasite produced during the final stage of the asexual cycle in humans. These gametocytes can infect female Anopheles mosquitoes, allowing the sexual cycle to continue. 

There are two types of gametocytes: microgametocytes, which are smaller and more numerous, and macrogametocytes, which are larger and less numerous. Microgametocytes produce eight flagellated microgametes through exflagellation, while macro gametocytes produce one macrogamete.

Various factors influence gametocyte development, including host immunity, parasite density, drug treatment, environmental conditions, and genetic factors. This process involves changes in gene expression, cell morphology, metabolism, and surface antigens. While the molecular mechanisms behind this process are not fully understood, scientists have identified several genes necessary for gametocytogenesis, including pvs25, pvs28, pvs47, and pvs48/45.

Sexual life cycle or sporogony in female Anopheles mosquito

Sporogony is the sexual phase of the Plasmodium vivax life cycle in the female Anopheles mosquito. During this phase, the gametocytes ingested by the mosquito during a blood meal undergo gametogenesis to form male and female gametes. These gametes fuse to form a zygote, which elongates and becomes motile to form an ookinete. 

The Sexual life cycle or sporogony in female Anopheles mosquito be divided into six steps:

Ingestion by mosquito

Ingestion by a mosquito is the first step in the sexual life cycle of Plasmodium vivax. This occurs when a female Anopheles mosquito feeds on an infected person’s blood. During this process, the mosquito’s mouthparts pierce the skin and inject saliva, which contains substances that prevent blood clotting and increase blood flow. As the mosquito feeds, it ingests red blood cells that contain P. vivax gametocytes, which are the sexual forms of the parasite. These gametocytes can survive in the mosquito’s gut and differentiate into male and female gametes. The mosquito’s digestive enzymes do not affect the gametocytes are not affected by and can survive in the blood meal for several hours. This step is crucial for transmitting P. vivax from one human host to another, as it allows the parasite to complete its sexual reproduction and produce sporozoites that can infect a new human host.

The mosquito’s digestive enzymes do not affect the gametocytes are not affected by and can survive in the blood meal for several hours. 

Gametogenesis/ Gametogony (Formation of gametes)

Gametogenesis, also known as gametogony, is the second step in the sexual life cycle or sporogony of Plasmodium vivax. It occurs in the mosquito’s midgut after the ingestion of gametocytes. During this process, the gametocytes differentiate into male and female gametes. The male gametocytes, or microgametocytes, undergo exflagellation, producing several flagellated microgametes. The female gametocytes, or macrogametocytes, mature into macrogametes.

Environmental cues in the mosquito’s midgut, such as changes in temperature and pH and the presence of a molecule called xanthurenic acid, trigger gametogenesis. These cues activate signaling pathways that regulate gene expression and cell differentiation in the gametocytes. The process of gametogenesis is rapid and synchronized, with most gametes forming within 15-20 minutes after ingesting the blood meal.

The formation of viable gametes is essential for completing the sexual life cycle of P. vivax, as it allows for fertilization and the production of sporozoites that can infect a new human host.

Fertilization

Fertilization is the third step in the sexual life cycle or sporogony of Plasmodium vivax. It occurs in the mosquito’s midgut after the formation of gametes. A microgamete fuses with a macrogamete to form a diploid zygote during this process. Specific proteins on their surfaces, such as Pvs 47 and Pvs 48/45 on the microgamete and Pvs 25 and Pvs 28 on the macrogamete, mediate the gametes’ fusion. These proteins are potential targets for transmission-blocking vaccines that aim to prevent fertilization and interrupt the life cycle of P. vivax.

Fertilization is a crucial step for the sexual reproduction and genetic recombination of P. vivax, as it allows for the production of genetically diverse offspring that can adapt to different hosts and environments.

Ookinete

Ookinete formation is the fourth step in the sexual life cycle or sporogony of Plasmodium vivax. It occurs in the mosquito’s midgut after fertilization. During this process, the zygote undergoes a series of morphological and metabolic changes to become a motile ookinete. The ookinete is a slender, elongated, and crescent-shaped cell with a single nucleus and two flagella. The ookinete secretes enzymes that help it penetrate the peritrophic matrix, a protective layer surrounding the blood meal in the mosquito’s gut.

Ookinete formation is an essential step for the survival and development of P. vivax, as it allows the parasite to escape from the hostile environment of the mosquito’s gut and reach the gut wall, where it can form an oocyst.

Encystment

Encystment is the fifth step in the sexual life cycle or sporogony of Plasmodium vivax. It occurs in the mosquito’s midgut after the ookinete penetrates the gut wall. During this process, the ookinete transforms into an oocyst, a round, thick-walled structure containing the developing sporozoites. The oocyst grows and expands by absorbing nutrients from the mosquito’s hemolymph, which circulates in its body cavity.

Encystment is crucial for protecting and developing P. vivax, as it allows the parasite to complete its sexual reproduction and produce sporozoites in a safe and nourishing environment. The oocyst wall is resistant to the mosquito’s immune defenses, such as melanization and encapsulation, and provides a physical barrier against environmental stresses.

Sporogony

Sporogony is the final stage in the sexual life cycle of Plasmodium vivax. This stage occurs within the oocyst, located in the mosquito’s midgut. During sporogony, the nucleus of the oocyst divides multiple times to produce thousands of haploid nuclei. The cytoplasm surrounds these nuclei to form sporoblasts, which eventually differentiate into sporozoites. Sporozoites are slender, elongated cells that have a single nucleus and an apical complex, an organelle that helps them invade host cells.

This stage is essential for the transmission and infection of P. vivax, as it allows the parasite to produce large numbers of sporozoites. These sporozoites migrate to the mosquito’s salivary glands and can be transmitted to a new human host when the mosquito takes its next blood meal.

Related: Malaria antigen test

Conclusion

Understanding the lifecycle of P. vivax is essential for developing effective strategies to control and eliminate this disease. The lifecycle presents several challenges for diagnosis, treatment, and prevention, including dormant liver stages, low-density infections, and genetic diversity among parasite populations. New biomarkers, drugs, vaccines, and vector control measures are needed to target different stages of the parasite’s lifecycle and interrupt transmission. Further research into the molecular and cellular mechanisms of P. vivax development and host-parasite interactions is also crucial for understanding the biology and epidemiology of this parasite.